New findings suggest concurrent liver diseases are increasing among adult liver transplant recipients in Australia and New Zealand, but do not seem to affect posttransplant survival.
The data additionally suggest these increases were predominantly driven by an increase in metabolic-associated fatty liver disease and alcohol-related liver disease. Read more in HCP Live.